enGene Therapeutics Inc.
ENGN- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001980845
In the last 90 days, enGene Therapeutics Inc. insiders filed 1 open-market purchase and 0 sales; 60 institutions reported holding it in 13F filings for Q2 2026, worth $86.5M in total; no superinvestor holds it.
Other share classesENGNW
13F holders, Q1 2025
Institutional positions in enGene Therapeutics Inc. as of Mar 31, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 31
- −3 vs. Q4 2024
- Shares held
- 40.9M
- −363.2K (−0.9%) vs. Q4 2024
- Total value
- $183.4M
- −$91.3M (−33.2%) vs. Q4 2024
- New holders
- 2
- 7 more added
- Sold out
- 5
- 8 more reduced
Compare with Q4 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting ENGN on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 60 | $86.5M |
| Q1 2026 | 62 | $383.0M |
| Q4 2025 | 58 | $530.8M |
| Q3 2025 | 37 | $279.1M |
| Q2 2025 | 36 | $147.1M |
| Q1 2025 | 31 | $183.4M |
| Q4 2024 | 34 | $274.7M |
| Q3 2024 | 30 | $227.7M |
| Q2 2024 | 30 | $307.1M |
| Q1 2024 | 31 | $536.1M |
| Q4 2023 | 11 | $130.9M |
| Q3 2023 | 0 | $0 |
| Q2 2023 | 0 | $0 |
| Q1 2023 | 0 | $0 |
| Q4 2022 | 0 | $0 |
| Q3 2022 | 0 | $0 |
| Q2 2022 | 0 | $0 |
| Q1 2022 | 0 | $0 |
| Q4 2021 | 0 | $0 |
| Q3 2021 | 0 | $0 |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2025
Shares, value and share of portfolio for each institution holding enGene Therapeutics Inc.; share changes are against Q4 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| FCPM III Services B.V. | 9,632,561 | $43.2M | 10.43% | 00.0% | Unchanged |
| VR Adviser, LLC | 5,046,414 | $22.6M | 1.92% | 00.0% | Unchanged |
| Kynam Capital Management, LP | 4,994,090 | $22.4M | 1.91% | 00.0% | Unchanged |
| Deep Track Capital, LP | 4,557,575 | $20.4M | 0.66% | 00.0% | Unchanged |
| Blue Owl Capital Holdings LP | 3,279,378 | $14.7M | 4.74% | +119,403+3.8% | Added |
| Cormorant Asset Management, LP | 2,323,595 | $10.4M | 0.79% | 00.0% | Unchanged |
| Bank of America Corp | 2,005,708 | $8.99M | 0.00% | +2,005,708 | New |
| Adage Capital Partners GP, L.L.C. | 1,571,642 | $7.04M | 0.01% | +41,874+2.7% | Added |
| Point72 Asset Management, L.P. | 1,241,188 | $5.56M | 0.02% | +16,391+1.3% | Added |
| Franklin Resources Inc | 1,174,866 | $5.26M | 0.00% | −15,086−1.3% | Reduced |
| Goldman Sachs Group Inc | 899,086 | $4.03M | 0.00% | 00.0% | Unchanged |
| OrbiMed Advisors LLC | 891,616 | $3.99M | 0.10% | −28,723−3.1% | Reduced |
| Sr One Capital Management, LP | 747,750 | $3.35M | 0.86% | 00.0% | Unchanged |
| Sphera Funds Management Ltd. | 528,365 | $2.37M | 0.58% | −31,635−5.6% | Reduced |
| Omega Fund Management, LLC | 526,357 | $2.36M | 1.39% | 00.0% | Unchanged |
| Morgan Stanley | 436,564 | $1.96M | 0.00% | −2,208−0.5% | Reduced |
| Vestal Point Capital, LP | 370,000 | $1.66M | 0.12% | 00.0% | Unchanged |
| Marshall Wace, LLP | 345,397 | $1.55M | 0.00% | −248,345−41.8% | Reduced |
| Schonfeld Strategic Advisors LLC | 134,084 | $600.7K | 0.00% | +1,824+1.4% | Added |
| MAI Capital Management | 78,067 | $349.7K | 0.00% | +7,756+11.0% | Added |
| Northern Trust Corp | 33,842 | $151.6K | 0.00% | −574−1.7% | Reduced |
| Geode Capital Management, LLC | 29,018 | $130.0K | 0.00% | 00.0% | Unchanged |
| ADAR1 Capital Management, LLC | 23,799 | $106.6K | 0.02% | +23,799 | New |
| Pale Fire Capital SE | 17,254 | $77.3K | 0.01% | +2,544+17.3% | Added |
| Two Sigma Investments, LP | 15,832 | $70.9K | 0.00% | −20,034−55.9% | Reduced |
| Toronto Dominion Bank | 14,537 | $65.1K | 0.00% | 00.0% | Unchanged |
| Sectoral Asset Management Inc | 11,700 | $52.4K | 0.04% | −67,219−85.2% | Reduced |
| Royal Bank of Canada | 7,915 | $35.0K | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 1,921 | $8.61K | 0.00% | +783+68.8% | Added |
| UBS Group AG | 1,200 | $5.38K | 0.00% | 00.0% | Unchanged |
| SBI Securities Co., Ltd. | 30 | $134 | 0.00% | 00.0% | Unchanged |
| BVF Inc | 0 | $0 | 0.00% | −2,106,037−100.0% | Sold out |
| Corton Capital Inc. | 0 | $0 | 0.00% | −23,601−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −15,342−100.0% | Sold out |
| Jane Street Group, LLC | 0 | $0 | 0.00% | −14,038−100.0% | Sold out |
| Vontobel Holding Ltd. | 0 | $0 | 0.00% | −10,417−100.0% | Sold out |